Luye Pharma
Yantai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A fully integrated pharmaceutical company commercializing innovative and generic drugs in oncology, CNS, and cardiovascular markets.
NeuroscienceOncologyCardiovascular
Technology Platform
Integrated R&D platform focusing on novel drug delivery systems (especially for CNS drugs) and the development of targeted small molecules and biosimilars.
Opportunities
Global expansion of its CNS franchise and successful launch of its late-stage oncology pipeline could drive significant growth.
Risk Factors
Pipeline execution risk and potential pricing pressure on both innovative and generic products in China and key international markets.
Competitive Landscape
Operates in highly competitive but large therapeutic markets, competing with multinational pharma giants and other large domestic players like Jiangsu Hengrui.